Acronym | EDENT1FI |
---|
Status | Active |
---|
Effective start/end date | 1/11/2023 → 31/10/2028 |
---|
- King's College London
- Cardiff University
- Critical Path Institute (C-Path) Amsterdam
- DiabetOmics, Inc
- Digostics Limited
- HANNOVERSCHE KINDERHEILANSTALT
- Helmholtz Zentrum München GmbH
- ImCyse SA
- IRCCS Ospedale San Raffaele
- KU Leuven (lead)
- Leona M & Harry B Helmsley Charitable Trust
- Medical University of Graz
- Medical University of Warsaw
- Medtronic Bakken Research Center B.V.
- Medtronic International Trading Sàrl
- Novo Nordisk A/S
- Provention Bio Inc.
- REGION HOVEDSTADEN
- Sanofi-Aventis Deutschland GmbH
- Sanofi US Services Inc.
- Sanofi-Aventis Recherche & Development
- TU Dresden
- University Hospital in Motol
- University of Birmingham
- University of Oxford
- University of Siena
- University of Silesia in Katowice
- University of Tampere
- University of Turku
- Associacao Protectora Dos Diabeticos De Portugal
- European Diabetes Forum AISBL
- JDRF International
- TSB Technology Strategy Board: £145,568.00